American Financial Network Advisory Services’s Supernus Pharmaceuticals SUPN Stock Holding History

American Financial Network Advisory Services’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-52	Closed	-$2K	–	533
2017 Q4	$2K	Hold	52	–	–	﹤0.01%	646
2017 Q3	$2K	Buy	+52	New	+$2.25K	﹤0.01%	707

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RCAMU

Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

American Financial Network Advisory Services's SUPN Position: Q1 2018 in Review

American Financial Network Advisory Services sold out of Supernus Pharmaceuticals (SUPN) in Q1 2018, closing a stake of 52 shares — an estimated $2K sold.

American Financial Network Advisory Services first reported a position in SUPN in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 312 funds tracked by Wall St. Rank hold SUPN as of Q1 2018.

American Financial Network Advisory Services reported no remaining Supernus Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
American Financial Network Advisory Services sold 52 Supernus Pharmaceuticals shares in Q1 2018, an estimated $2K.
American Financial Network Advisory Services first reported a position in Supernus Pharmaceuticals in Q3 2017 and held it in 2 quarters.
American Financial Network Advisory Services's Supernus Pharmaceuticals position peaked at $2K in Q4 2017.
312 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2018.

Based on American Financial Network Advisory Services's 13F filing for Q1 2018, filed 15 May 2018.